RxDoctor Payments DataLook up a doctor →

Kerry Solomon, MD

Ophthalmology · Mt Pleasant, SCNPI 1881608024

Payments from drug & device makers

$4,584,541in general payments, 2019–2025

Across 1,430 payments — averaging $3205.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon Research LLC$1.4M
  • Johnson & Johnson Surgical Vision, Inc.$1.2M
  • Carl Zeiss Meditec Digital Innovations LLC$964K
  • Rxsight Inc$449K
  • Alcon$422K
  • Carl Zeiss Meditec, Inc.$131K
  • plus $74K from 12 others
$52,512in research payments, 2019–2025

Across 59 payments — averaging $890.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Rxsight Inc$33K
  • Johnson & Johnson Surgical Vision, Inc.$19K

What the payments were for

  • Consulting fees$1,640,89594%
  • Speaking & faculty fees$25,5011%
  • Travel & lodging$43,0082%
  • Food & beverage$17,0581%
  • Education$2,2500%
  • Gifts$11,6831%
  • Entertainment$1060%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,584,541 in reported general payments places this provider in the 95th percentile of 293 ophthalmology providers in South Carolina.

See all ophthalmology providers in South Carolina

Medicare billing

Part B allowed, 2024
$784,730
Medicare patients
1,112
Services billed
3,674

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Loteprednol Etabonate11$2,437
Prednisolone Acetate39$1,970
Ketorolac Tromethamine30$1,095
Ofloxacin38$555

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Mt Pleasant

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →